COMMUNIQUÉS West-GlobeNewswire
-
Easy Environmental Solutions Ships First Commercial EasyFEN™ System to Kenya
01/10/2026 -
RenovoRx Announces Peer-Reviewed Publication Highlighting the TAMP™ Platform's Potential to Improve Chemotherapeutic Delivery for Locally Advanced Pancreatic Cancer
01/10/2026 -
TOMI Environmental Solutions Expands SteraMist iHP into India's Pharmaceutical Market Through Partner STS Technocrat (India) Pvt. Ltd.
01/10/2026 -
Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer
01/10/2026 -
Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, Marking a Major Step in its Transition Toward Commercial Revenue Generation
01/10/2026 -
Spectral AI Announces First Site Initiation Visit for DeepView System™ Clinical Study Supporting Label Expansion Strategy to Burns of the Head, Hands, and Feet
01/10/2026 -
SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D Clinical & Research Congress
01/10/2026 -
ViroMissile Completes First Dose Cohort of Phase I Trial of Intravenously-Dosed IDOV-2; Safety Review Committee Clears Advancement to Next Cohort
01/10/2026 -
Akari Therapeutics Expands Intellectual Property Portfolio with PCT Filing for ADC Payload Related to RNA Splicing in Cancers
01/10/2026 -
MitoRx Therapeutics presents new preclinical data on MTRX31, demonstrating restored mitochondrial density, at the 62nd EASD Annual Meeting
01/10/2026 -
Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences
01/10/2026 -
Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
01/10/2026 -
Kyntra Bio Appoints Andrew E. Singer, MBA to its Board of Directors
01/10/2026 -
Kailera Therapeutics Presents New Clinical Data at EASD 2026 Annual Meeting
01/10/2026 -
Novo’s Wegovy® (semaglutide) reduced liver fat to normal levels in 9 out of 10 adults with obesity and excess liver fat – EASD2026
01/10/2026 -
Agomab Reports Positive Topline Data from STENOVA Open-Label Extension Study of Ontunisertib in Fibrostenosing Crohn's Disease
01/10/2026 -
Nxera Announces Successful Resolution of miniG Patent Infringement Action
01/10/2026 -
RadNet and WIN-NextGen™ Form a Collaboration to Inspire the Next Generation of Medical Imaging Professionals
01/10/2026 -
Kestra Medical Technologies Earns Five-Star Rating on Newsweek’s List of America’s Greatest Mid-Market Companies
01/10/2026
Pages